EcoDrugPlus

Ribosomal Protein S28

Ensembl ID : ENSPCTG00005013385
Gene Symbol: RPS28
3 Cross references
187 Possible Orthologues:

Ribosomal Protein S3

Ensembl ID : ENSPCTG00005012736
Gene Symbol: RPS3
3 Cross references
147 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSPCTG00005013464
Gene Symbol: RPS5
3 Cross references
257 Possible Orthologues:

Ribosomal Protein S6

Ensembl ID : ENSPCTG00005015082
Gene Symbol: RPS6
3 Cross references
149 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSPCTG00005006998
Gene Symbol: RPS9
3 Cross references
219 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSPCTG00005019449
Gene Symbol: RPLP0
3 Cross references
173 Possible Orthologues:

Secretin Receptor

Ensembl ID : ENSPCTG00005003306
Gene Symbol: SCTR
1 Cross references
130 Possible Orthologues:

Selectin L

Ensembl ID : ENSPCTG00005003917
Gene Symbol: SELL
1 Cross references
86 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSPCTG00005002773
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Beta Subunit

Ensembl ID : ENSPCTG00005006987
Gene Symbol: SCNN1B
3 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSPCTG00005013833
Gene Symbol: SCNN1A
1 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSPCTG00005006928
Gene Symbol: SCNN1G
1 Cross references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).